Delivery Order SPE2DB20D2104-SPE2DB25F1428

Award Date 11/6/24
Potential Completion Date 11/7/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $11,208.78, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is a delivery order contract for the supply of Eliquis 5 mg tablets. It is a firm-fixed-price contract with an ultimate completion date of February 3, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award, valued at $37,570.28, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566495042 - Eliquis 5 mg Tablet 60s, a prescription medication. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of November 21, 2024. This award is not associated with a set-aside...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Eliquis 5 mg tablets. The $23,951.03 firm fixed price contract has an ultimate completion date of October 24, 2024. It is a delivery order under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award, valued at $6,479.13, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract provides for the delivery of Eliquis 5 mg tablets to support federal healthcare programs. This contract is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $7,770.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, a delivery order contract, is for the supply of Eliquis 5 mg tablets. The contract has a firm fixed-price pricing type and an ultimate completion date of November 17, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award, valued at $3,745.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract with a Firm Fixed Price pricing type for the supply of Eliquis 5 mg tablets. The contract has an ultimate completion date of November 29, 2023 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,265.64, is for the supply of Eliquis 5 mg tablets to meet the medical needs of federal government agencies and programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $10,832.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the pharmaceutical product Eliquis 5 mg tablet, 60 count, with a performance period running through January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, worth $10,495.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the procurement of Eliquis 5 mg tablets, a brand-name pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 8, 2023. This award does not have any set-aside designation, indicating it was open to full and open competition....
This federal contract award, valued at $16,031.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract to supply 4,567,998,897 units of the medication Eliquis 5 mg tablets. The contract has a firm fixed price and an ultimate completion date of April 23, 2025. This award is not associated with a set-aside program and represents open competition. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25F1428
    Delivery Order

This federal contract award, valued at $11,824.70, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type and covers the supply of 4566413700 - Eliquis 5 mg Tablet 60s, a pharmaceutical product. The award has an ultimate completion date of November 7, 2024.

The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization and a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the DLA and Department of Justice Federal Bureau of Investigation, through Indefinite Delivery Contracts (IDCs) valued at $999,999,999 and $750,000 respectively. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/20/25, 1:55 PM